How 3D genomics can accelerate personalised medicine
Drug Discovery World
JULY 23, 2024
Dr Daniel Turner, Chief Scientific Officer, Enhanc3D Genomics, outlines how 3D genomics offers a radically novel approach to address challenges in drug target discovery and how it can affect change in drug target identification, cell therapy and personalised medicine.
Let's personalize your content